Patents by Inventor Dirk Kaiser

Dirk Kaiser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substance for the Treatment of Infections
    Publication number: 20080213391
    Abstract: The invention relates to the use of dichloric acids and the derivatives thereof for producing medicaments used for disinfecting body cavities.
    Type: Application
    Filed: February 10, 2006
    Publication date: September 4, 2008
    Applicant: Templa Tech GmbH
    Inventors: Dirk Kaiser, Mark-Andre Freyberg
  • Method for Manufacturing Specific Binding Molecules Against Selected Target Molecules, Kit, and Binding Molecules
    Publication number: 20080003563
    Abstract: A method for the isolation of specific molecules which bind highly selectively to chosen target molecules. In particular, due to displacement with a specific competitor, binding molecules are selected which preferably bind to previously known epitopes.
    Type: Application
    Filed: April 29, 2005
    Publication date: January 3, 2008
    Inventors: Gerd Klock, Dirk Kaiser, Mark Freyberg
  • Anti-apoptotically active apatamers
    Publication number: 20070117768
    Abstract: The invention relates to anti-apoptotically active apatamers. The invention describes possible therapeutic and diagnostic applications for, among other things, treating arteriosclerosis, promoting the healing of wounds, treating AIDS, cancer, Alzheimer's disease, systemic lupus erythematosus as well a rheumatoid arthritis and other chronic inflammatory diseases.
    Type: Application
    Filed: December 10, 2004
    Publication date: May 24, 2007
    Applicant: CYTOTOOLS GMBH
    Inventors: Gerd Klock, Mark Freyberg, Dirk Kaiser
  • Dichloric acids, reactive chlorine compounds, their derivatives, anions and salts, as well as processes for their manufacture and use
    Publication number: 20070054959
    Abstract: This invention relates to aqueous solutions of reactive chlorine compounds having the empirical formulae H2Cl2O6 or ClO3H, for example, and the derivatives, anions or salts thereof. The invention further relates to methods for the production of said compounds and the use thereof in the pharmaceutical and particularly in the medical field, in cosmetics, medicinal care and in the domains of food technology and technology.
    Type: Application
    Filed: November 22, 2004
    Publication date: March 8, 2007
    Applicant: CYTOTOOLS GMBH
    Inventors: Klaus Wannowius, Dirk Kaiser
  • Method for identifying active anti-apoptosis compounds
    Publication number: 20060172921
    Abstract: The invention relates to a method for identifying substances with antiapoptotic activity, where i) cells which express both CD47 and the integrin ?v?3 are cultured, ii) the cells are caused to produce an apoptosis-inducing substance, and/or a substance or substances which induces/induce apoptosis is/are added, iii) the test substance is added, and iv) the apoptosis rate is measured, and to the substances which can be identified with the method.
    Type: Application
    Filed: January 6, 2006
    Publication date: August 3, 2006
    Applicant: CYTOTOOLS GMBH
    Inventors: Mark Freyberg, Peter Friedl, Dirk Kaiser
  • Method for identifying active anti apoptosis compounds
    Patent number: 7008773
    Abstract: The invention relates to a method for identifying substances with antiapoptotic activity, where i) cells which express both IAP and the integrin ?v?3 are cultured, ii) the cells are caused to produce an apoptosis-inducing substance, and/or a substance or substances which induces/induce apoptosis is/are added, iii) the test substance is added, and iv) the apoptosis rate is measured, and to the substances which can be identified with the method.
    Type: Grant
    Filed: November 2, 2000
    Date of Patent: March 7, 2006
    Assignee: CytoTools GmbH
    Inventors: Mark A. Freyberg, Peter Friedl, Dirk Kaiser
  • Apoptotically active peptides
    Publication number: 20050222020
    Abstract: Specific amino acid sequences and peptides and/or peptide mimetics deducted therefrom influencing apoptosis, and the use thereof for the production of pharmaceuticals as diagnostic tools are shown.
    Type: Application
    Filed: December 18, 2002
    Publication date: October 6, 2005
    Inventors: Mark Freyberg, Peter Friedl, Dirk Kaiser
  • Agents, which inhibit apoptosis in cells that are involved in wound healing
    Publication number: 20040101526
    Abstract: The invention relates to the use of substances as a fundamental constituent in wound healing agents. The invention is characterised in that said substances hond to either IAP and/or integrin &agr;v&bgr;3 and/or thrombuspondin-1 in such a way that the bond between thrumbospondin-1 and IAP and/or integrin &agr;v&bgr;3 is inhibited.
    Type: Application
    Filed: August 25, 2003
    Publication date: May 27, 2004
    Inventors: Mark A. Freyberg, Peter Friedl, Dirk Kaiser